The enoyl-[acyl-carrier-protein] reductase (FabI) of Escherichia coli, which catalyzes a key regulatory step in fatty acid biosynthesis, accepts NADH and NADPH as cofactors and is inhibited by palmitoyl-CoA - PubMed (original) (raw)
The enoyl-[acyl-carrier-protein] reductase (FabI) of Escherichia coli, which catalyzes a key regulatory step in fatty acid biosynthesis, accepts NADH and NADPH as cofactors and is inhibited by palmitoyl-CoA
H Bergler et al. Eur J Biochem. 1996.
Free article
Abstract
Reduction of enoyl-acyl-carrier-protein (ACP) substrates by enoyl-ACP reductase is a key regulatory step in fatty acid elongation of Escherichia coli. Two enoyl-ACP reductase activities have been described in E. coli, one specific for NADH, the other for NADPH as cofactor. Because of their distinct enzymatic properties, these activities were ascribed to two different proteins. The NADH-dependent enoyl-ACP reductase of E. coli has previously been identified as the FabI protein, which is the target of a group of antibacterial compounds, the diazaborines. We now demonstrate that both enoyl-ACP reductase activities reside in FabI. In crude cell extracts of FabI-overproducing strains, both NADH-dependent and NADPH-dependent enoyl-ACP reductase activities are increased. Mutations in the fabI gene that lead either to temperature-sensitive growth or diazaborine resistance result in the reduction of both activities. When FabI is purified in pH 6.5 buffers, the protein exhibits NADH-dependent and NADPH-dependent reductase activities. Both enzymatic activities are inhibited by diazaborine. The NADPH-dependent enoyl-ACP reductase activity, however, turned out to be approximately eight times more resistant to diazaborine. The difference in sensitivity indicates that binding of either NADPH or NADH to FabI results in distinct changes in the configuration of the protein or, alternatively, it is different due to the different charge of the cofactors. These effects might be responsible for the differences in the enzymatic properties. Both reductase activities of the FabI protein are inhibited by physiologically relevant concentrations of palmitoyl-CoA, which might be important in regulating endogenous fatty acid biosynthesis in E. coli in the presence of exogenous fatty acids.
Similar articles
- Enoyl-acyl carrier protein reductase (fabI) plays a determinant role in completing cycles of fatty acid elongation in Escherichia coli.
Heath RJ, Rock CO. Heath RJ, et al. J Biol Chem. 1995 Nov 3;270(44):26538-42. doi: 10.1074/jbc.270.44.26538. J Biol Chem. 1995. PMID: 7592873 - Protein EnvM is the NADH-dependent enoyl-ACP reductase (FabI) of Escherichia coli.
Bergler H, Wallner P, Ebeling A, Leitinger B, Fuchsbichler S, Aschauer H, Kollenz G, Högenauer G, Turnowsky F. Bergler H, et al. J Biol Chem. 1994 Feb 25;269(8):5493-6. J Biol Chem. 1994. PMID: 8119879 - The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis.
Heath RJ, Su N, Murphy CK, Rock CO. Heath RJ, et al. J Biol Chem. 2000 Dec 22;275(51):40128-33. doi: 10.1074/jbc.M005611200. J Biol Chem. 2000. PMID: 11007778 - FabI (enoyl acyl carrier protein reductase) - A potential broad spectrum therapeutic target and its inhibitors.
Rana P, Ghouse SM, Akunuri R, Madhavi YV, Chopra S, Nanduri S. Rana P, et al. Eur J Med Chem. 2020 Dec 15;208:112757. doi: 10.1016/j.ejmech.2020.112757. Epub 2020 Aug 23. Eur J Med Chem. 2020. PMID: 32883635 Review. - Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
Lu H, Tonge PJ. Lu H, et al. Acc Chem Res. 2008 Jan;41(1):11-20. doi: 10.1021/ar700156e. Acc Chem Res. 2008. PMID: 18193820 Review.
Cited by
- Unravelling the physicochemical and antimicrobial mechanisms of human serum albumin/tannic acid coatings for medical-grade polycaprolactone scaffolds.
Cometta S, Donose BC, Juárez-Saldivar A, Ravichandran A, Xu Y, Bock N, Dargaville TR, Rakić AD, Hutmacher DW. Cometta S, et al. Bioact Mater. 2024 Aug 28;42:68-84. doi: 10.1016/j.bioactmat.2024.08.023. eCollection 2024 Dec. Bioact Mater. 2024. PMID: 39280579 Free PMC article. - Impact of trifluoromethyl and sulfonyl groups on the biological activity of novel aryl-urea derivatives: synthesis, in-vitro, in-silico and SAR studies.
Sroor FM, Mahrous KF, El-Kader HAMA, Othman AM, Ibrahim NS. Sroor FM, et al. Sci Rep. 2023 Oct 16;13(1):17560. doi: 10.1038/s41598-023-44753-9. Sci Rep. 2023. PMID: 37845243 Free PMC article. - Comparative genomics hints at dispensability of multiple essential genes in two Escherichia coli L-form strains.
Liu Y, Zhang Y, Kang C, Tian D, Lu H, Xu B, Xia Y, Kashiwagi A, Westermann M, Hoischen C, Xu J, Yomo T. Liu Y, et al. Biosci Rep. 2023 Oct 31;43(10):BSR20231227. doi: 10.1042/BSR20231227. Biosci Rep. 2023. PMID: 37819245 Free PMC article. - Molecular Modelling Study and Antibacterial Evaluation of Diphenylmethane Derivatives as Potential FabI Inhibitors.
Hasan S, Kayed K, Ghemrawi R, Bataineh NA, Mahgoub RE, Audeh R, Aldulaymi R, Atatreh N, Ghattas MA. Hasan S, et al. Molecules. 2023 Mar 28;28(7):3000. doi: 10.3390/molecules28073000. Molecules. 2023. PMID: 37049763 Free PMC article. - Unsaturated fatty acid synthesis in Enterococcus faecalis requires a specific enoyl-ACP reductase.
Dong H, Cronan JE. Dong H, et al. Mol Microbiol. 2022 Nov;118(5):541-551. doi: 10.1111/mmi.14981. Epub 2022 Oct 1. Mol Microbiol. 2022. PMID: 36100979 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases